Categories: NewsPharmaceutical

Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

DURHAM, N.C., July 27, 2023 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Thursday, August 3, 2023 at 8:30 a.m. ET to report financial results for the second quarter ended June 30, 2023, and to provide a business overview.

To access the live conference call, please dial (646) 307-1963 (domestic) or (800) 715-9871 (international) at least five minutes prior to the start time, and refer to conference ID 8015897. A live audio webcast of the call will also be available on the Investors’ section of the Company’s website, www.chimerix.com. An archived webcast will be available on the Chimerix website approximately two hours after the event.

About Chimerix

Chimerix is a biopharmaceutical company with a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The Company’s most advanced clinical-stage development program, ONC201, is in development for H3 K27M-mutant glioma.

CONTACTS:      

Michelle LaSpaluto
919 972-7115
ir@chimerix.com

Will O’Connor
Stern Investor Relations
212-362-1200
will@sternir.com

Staff

Recent Posts

CDx Diagnostics to Present WATS3D Progression Data at DDW 2025

Highlights Continued Progress in Early Detection and the Progression of Esophageal Disease SUFFERN, N.Y., May…

5 minutes ago

Life Science Analytics Market worth $68.81 billion by 2030 11.4% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., May 2, 2025 /PRNewswire/ -- The global Life Science Analytics Market , valued…

5 minutes ago

Landmark Science Makes RWE Services for Biopharma Industry a Boutique Experience

LOS ANGELES, May 2, 2025 /PRNewswire/ -- Landmark Science, a premier provider of real-world evidence…

5 minutes ago

The Royal Marsden first center in the world to treat a patient using the new adaptive replanning module in RayStation for online adaptive radiotherapy treatment

STOCKHOLM, May 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce that…

5 minutes ago

Glowbar Launches First Philanthropic Partnership with Melanoma Research Foundation as Part of 2025 #GetNaked Campaign

The fastest-growing and largest facial membership brand is promoting sun safety and melanoma awareness by…

5 minutes ago

Cantata Health Solutions Launches Medication-Assisted Treatment (MAT) Module in Arize EHR

Integrated system supports methadone dispensing services within a whole-person approach to behavioral healthcare LAKEWAY, Texas,…

5 minutes ago